“…The risk of needle tracking depends on size of the tumor, thickness of hepatic parenchyma, number of needle passes, tumor grade, and type of needle used. [15] In the present study population, no complications occurred during and after the procedure. The incidence of needle track seedling was 0.6% (one of 148 patients of HCC) in study done by Reddy et al [16] Among the 13 cases of ovarian masses, most common lesions were malignant (eight cases, 61.54%); a similar observation was made out in the study done by Sobha et al [17] (58.3%) and Pranab et al [18] (87.5%), which was different from the observation made by Sidhalingreddy and Andola.…”